Last edition
News about Global Pharma
This innovation provides oncologists with real-time visual evidence of chemotherapy drugs' effectiveness on a patient's tumor cells, derived from tissue biopsies or blood.
Global Pharma | 28/01/2025 | By Manvi | 193
Curiox Biosystems Rolls Out Curiox C- Free Pluto ALPHA
The Curiox C- Free Pluto ALPHA replaces traditional centrifuge-based methods, offering a low-maintenance solution that eliminates bulky hardware.
Global Pharma | 27/01/2025 | By Aishwarya | 945
Biocon's S&P Global ESG Score Improves to 69 for 2024, Up by 6 Points from 2023
Biocon Ltd., a global biopharmaceutical company, achieved a 6-point rise in its S&P Global ESG Score to 69 in 2024, ranking in the 98th percentile among biotechnology peers, with standout scores in Environmental (76), Social (74), and Governance (62) dimensions.
Global Pharma | 27/01/2025 | By Manvi | 264
Zydus's Chairman Pankaj R Patel Conferred with Padma Bhushan
With a Masters in Pharmaceutics and Pharmaceutical Technology from the L.M. College of Pharmacy and an alumni of the Indian Institute of Management (IIM), Ahmedabad, he was always driven by a passion to become a pharma entrepreneur.
Global Pharma | 27/01/2025 | By Aishwarya | 637
AstraZeneca To Invest CAD 820 Mn in Canada to Boost Clinical Delivery Sector
New investment in Canada will contribute to AstraZeneca’s global ambition to achieve USD80 billion in Total Revenue and to bring 20 new medicines to patients around the world by 2030 of which eight new medicines have been delivered to date.
Global Pharma | 27/01/2025 | By Aishwarya | 422
CStone Join Hands with SteinCares to Commercialize Sugemalimab in Latin America
As part of this collaboration, SteinCares will be responsible for the regulatory affairs and commercialization activities of sugemalimab in these regions.
Global Pharma | 27/01/2025 | By Aishwarya | 405
AbbVie Finalises Acquisition of Nimble Therapeutics
AbbVie has completed its acquisition of Nimble Therapeutics, adding Nimble's novel oral peptide IL23R inhibitor for psoriasis and proprietary peptide discovery platform to its immunology pipeline.
Global Pharma | 24/01/2025 | By Manvi | 426
Veeva and Zifo to Accelerate Quality Control Modernization
By bringing together Veeva LIMS with Zifo’s data integration and management platform, qcKen, companies can import data directly from any source document or other LIMS into Veeva LIMS.
Global Pharma | 24/01/2025 | By Aishwarya | 898
Medix Biochemica Announces Acquisition of CANDOR Bioscience
The acquisition both strengthens Medix Biochemica’s range of high-quality raw materials to the worldwide IVD industry and enhances its capabilities to support test manufacturers in immunoassay development.
Global Pharma | 24/01/2025 | By Aishwarya | 391
Piramal Critical Care Launches Chlorpromazine Hydrochloride for Injection, USP in US
Piramal Critical Care (PCC), a division of Piramal Pharma Ltd., has launched Chlorpromazine Hydrochloride for Injection, USP to be offered in 25mg/1mL and 50mg/2mL vials in the US, expanding its generic injectables portfolio.
Global Pharma | 23/01/2025 | By Manvi | 283
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy